Oxygen (CPB 0002, reviewed 2026-03-10)

By March 10, 2026 (or immediately if already implemented): (1) Billing and Prior Authorization teams must implement prior authorization requirements for all home oxygen therapy claims, requiring documentation of: physician determination of severe lung disease or hypoxia symptoms, qualifying blood gas study results (arterial PO2 ≤55 mmHg, arterial O2 saturation ≤88%, OR arterial PO2 56-59 mmHg with dependent edema/P pulmonale/erythrocythemia), timing requirements for blood gas studies (per policy conditions), and evidence that alternative treatments were tried or deemed clinically ineffective. (2) Update claim submission requirements to mandate: diagnosis documentation against approved list (COPD, bronchiectasis, cystic fibrosis, diffuse interstitial lung disease, BPD, pulmonary neoplasm, erythrocytosis, pulmonary hypertension, cor-pulmonale, cluster headaches, hemoglobinopathies, or obstructive sleep apnea with hypoxemia). (3) Implement system rules to DENY or REQUEST MEDICAL REVIEW for: asthma, bronchitis, croup, pneumonia oxygen therapy lasting >1 month without special circumstances; all other non-approved indications; angina without hypoxemia; dyspnea without cor pulmonale; peripheral vascular disease without systemic hypoxemia; and terminal non-respiratory illnesses. (4) Configure billing system to enforce delivery system restrictions: deny preset portable units; deny duplicate systems; deny spare tanks except for continuous oxygen dependent members; deny ambulatory/portable concentrators for sleep-only qualifying patients; deny emergency/standby systems. (5) Establish recurring reassessment protocol requiring independent respiratory provider testing at 12 months (for PO2 ≤55 or O2 sat ≤88%) or 3 months (for PO2 56-59 or O2 sat 89% with dependent edema/P pulmonale/erythrocythemia) through Aetna-participating supplier unaffiliated with current provider. (6) For obstructive sleep apnea cases, require documentation of minimum 2-hour PAP titration with AHI/RDI ≤10 events/hour, nocturnal oximetry post-titration during optimal PAP settings, and polysomnographic study showing O2 saturation ≤88%. (7) Apply 5-year reasonable useful lifetime (RUL) from initial service date for all equipment; select rental or purchase based on cost-effectiveness. (8) Front desk and clinical staff must verify all prior authorization is obtained before claim submission. Failure to comply with these requirements will result in claim denials and potential member liability disputes.